However, it is possible that the association of IL-6 with prostate cancer risk could be modified by BMI, as increasing IL-6 was positively associated with prostate cancer in normal-weight subjects, but inversely associated with prostate cancer in overweight/obese men [177]. The gene discussed is IL6; the disease is prostate carcinoma.